People struggling with significant weight or metabolic concerns need more than a patch
In animal studies, resmetirom increases the expression of genes involved in fatty acid oxidation ( CPT1A , ACOX1 ), mitochondrial biogenesis ( PPARGC1A ), and cholesterol catabolism ( CYP7A1 ), while reducing levels of lipogenic targets ( SREBP-1c , FASN ) [1921]
Recent studies show the FDA is now exploring GLP-1s as a potential medication-assisted treatment for addiction
Higher protein intake is especially important since GLP-1 medications can significantly reduce appetite
This includes follow-up care, ongoing lifestyle coaching, and access to additional resources to ensure that patients have the tools they need to sustain their healthy habits and prevent weight regain
doi: 10.1210/JC.2017-00970 9 TangSTangHSuHWangYZhouQZhangQet al